Longeveron Inc - Ordinary Shares - Class A Stock, NASDAQ:LGVN
Life Science & Technology Park, 1951 NW 7th Avenue, Miami, Florida 33136
United States of America
Number of Employees: 18
Longeveron, Inc. is a clinical stage biotechnology company. It engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers on October 9, 2014 and is headquartered in Miami, FL.